Fundraising FoxInnervace
New York, US · Founded 2020 · Delaware corporation · 2 known investors
Find your way into Innervace
Sign up to find every way you can get introduced to Innervace
- Your email: who you already know at Innervace, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Innervace team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
NH
Nader HalimNamed on SEC filing
AS
Althea StillmanNamed on SEC filing
Board
JL
DG
Investors · 2
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · press coverage · funding news · Not right? Tell us
Deerfield Management CompanyreportedNew Yorkvia Jonathan Leff · board
How we know: board seat on SEC Form D · press coverage · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2022
▶$10MraisedAug 2022 · 7 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nader HalimExecutive Officer, Director
- Jonathan LeffDirector
- Althea StillmanExecutive Officer, Director
- David GreenwaldDirector
- Offering amount
- $40M
- Amount sold
- $10M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Innervace's investors?
- Innervace's investors include BioAdvance, Deerfield Management Company.
- How much funding has Innervace raised?
- Innervace has disclosed $10M raised across 1 round.
- Where is Innervace headquartered?
- Innervace is headquartered in New York, US.